Moderna(@moderna_tx):Along with our partners at @Merck, we announced positive results from the Phase 3 INTerpath-001 study of intismeran autogene, our investigational individualized neoantigen therapy, in combination with pembrolizumab as adjuvant treatment in patients with completely resected Stage IIB-IV melanoma. This marks the first and only combination regimen to demonstrate a clinically meaningful improvement over pembrolizumab alone, a current standard-of-care for these patients. In our latest IR Insights, members of our executive team sat down to reflect on what this means:

Moderna

@moderna_tx

Our mission is to deliver the greatest possible impact to people through mRNA medicines.

参加 December 2013

541 フォロー中 145.4K ファン

Moderna@moderna_tx

2026.08.19 17:08

Along with our partners at @Merck, we announced positive results from the Phase 3 INTerpath-001 study of intismeran autogene, our investigational individualized neoantigen therapy, in combination with pembrolizumab as adjuvant treatment in patients with completely resected Stage IIB-IV melanoma. This marks the first and only combination regimen to demonstrate a clinically meaningful improvement over pembrolizumab alone, a current standard-of-care for these patients. In our latest IR Insights, members of our executive team sat down to reflect on what this means: